Member Info for Spinal_Tap

Excellent news.

The graphite production alone could be worth up £100m per year.

Great to see the progress being made at Imm. Well done Tim, you are doing a tremendous job.

Approx Immupharma share price £345. That would be quite the return from 4p currently.

Laura, Thank you for your comprehensive breakdown. £354 per share sounds phenomenal. 🤞

Because I believe Tim is a man of his word and great integrity.

I disagree. We are about to see momentum moving positively.

I just think that with the share price at 4p the risk/reward is worth it in my opinion. Yes, it could drop by a half, or go up 1000%.

Or Merck. $274 billion.

Nice 200k buy just gone through.

Is news about to come out?

Loving your work Big Sid.

I look at it another way. The big pharmaceutical companies are doing there thorough examination prior to either a major deal or offer for the company. IMHO.

I’d be happy with just a £250m deal.

Hopeful we will get news tomorrow.

Fair point bamb.

Bought in at .1 early last week. Saw the RNS on Friday and thought wow this is incredible news, which I think long term it will be. In some ways, I was happy to see the steady growth they were making, without the 100 MW news that came on Friday - are they going to have to raise some cash by a dilution of shares? And the move into bitcoin and the stated 8.3 bitcoins they will mine each year that is surely a variable and not so sure it will hit $120k price again so quickly. Still excited about this share, but kind of understand why the market is a little hesitant.

According to Google, Building an AI-optimized data center in 2026 typically costs over $20 million per megawatt (MW) for construction, nearly double the cost of standard data centers. For a standard 100-megawatt (MW) hyperscale facility, initial construction—including land, shell, and power/cooling—ranges from $900 million to $1.5 billion.

So am I right in saying AEG can provide 100MW for just $30m. 100 x $300,000?

A conservative estimate in the short term I reckon.

£106,000 from James Stenhouse, the newly appointed Non-Executive Director of the Company.

He certainly seems to be backing the company.